Nader Al Nakouzi

Vancouver, BC V5Z1M9, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.

Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.

Journal: Molecular cell

Published: May 27, 2019

Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.

Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 01, 2018

Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.

Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.

Journal: Molecular cancer therapeutics

Published: February 07, 2018

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.

SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.

Journal: EMBO molecular medicine

Published: January 20, 2018

Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.

Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.

Journal: Oncogene

Published: July 19, 2017

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.

Journal: EMBO molecular medicine

Published: May 21, 2016

Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.

Oncofetal Chondroitin Sulfate Glycosaminoglycans Are Key Players in Integrin Signaling and Tumor Cell Motility.

Journal: Molecular cancer research : MCR

Published: April 06, 2016

Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.

Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.

Journal: Cancer cell

Published: June 12, 2015

Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth.

Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 01, 2014

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.

Journal: Oncotarget

Published: February 15, 2014

Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.

Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.

Journal: European urology

Published: January 19, 2014

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

Journal: Cancer research

Published: October 31, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026